首页 | 本学科首页   官方微博 | 高级检索  
   检索      


High-conductance calcium-activated potassium channels; Structure,pharmacology, and function
Authors:Gregory J Kaczorowski  Hans -Günther Knaus  Reid J Leonard  Owen B McManus  Maria L Garcia
Institution:(1) Merck Research Laboratories, P.O. Box 2000, 07065 Rahway, New Jersey;(2) Institute for Biochemical Pharmacology, University of Innsbruck, Peter-Mayr Strasse 1, A-6020 Innsbruck, Austria
Abstract:High-conductance calcium-activated potassium (maxi-K) channels comprise a specialized family of K+ channels. They are unique in their dual requirement for depolarization and Ca2+ binding for transition to the open, or conducting, state. Ion conduction through maxi-K channels is blocked by a family of venom-derived peptides, such as charybdotoxin and iberiotoxin. These peptides have been used to study function and structure of maxi-K channels, to identify novel channel modulators, and to follow the purification of functional maxi-K channels from smooth muscle. The channel consists of two dissimilar subunits, agr and Bgr. The agr subunit is a member of theslo Ca2+-activated K+ channel gene family and forms the ion conduction pore. The Bgr subunit is a structurally unique, membrane-spanning protein that contributes to channel gating and pharmacology. Potent, selective maxi-K channel effectors (both agonists and blockers) of low molecular weight have been identified from natural product sources. These agents, together with peptidyl inhibitors and site-directed antibodies raised against agr and Bgr subunit sequences, can be used to anatomically map maxi-K channel expression, and to study the physiologic role of maxi-K channels in various tissues. One goal of such investigations is to determine whether maxi-K channels represent novel therapeutic targets.
Keywords:maxi-K channels  charybdotoxin  iberiotoxin  smooth muscle  ion channel purification  slo channels  Bgr-subunit" target="_blank">gif" alt="Bgr" align="BASELINE" BORDER="0">-subunit  K channel agonists  K channel blockers  ion channel pharmacology
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号